Follow-up studies also suggested AHRR methylation in blood as a biomarker for cardiovascular disease in the Caucasian population, such as myocardial infarction, ischemic heart disease, ischemic stroke, and heart failure, as well as a predictor of the risk of all-cause mortality [33–36]. This evidence concerns the gene AHRR and cardiovascular disorder.